Novel ADAMTS13 Fusion Construct Targets Dual Mechanisms in Immune-Mediated TTP – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Yunpeng Xue et al, adding:
“ADAMTS 13 fusion constructs with dual activity against von Willebrand factor: a novel strategy for immune mediated thrombotic thrombocytopenic purpura
This laboratory study combines an autoantibody-resistant ADAMTS 13 variant with a single-domain antibody targeting active von Willebrand factor.
The fusion construct retained VWF cleaving activity while reducing platelet VWF interactions.
In assays using plasma from patients with immune mediated TTP, the engineered construct showed greater resistance to inhibitory autoantibodies.
The work explores a dual action strategy against the molecular drivers of iTTP.
Patient efficacy and safety have not been established by these experimental findings.”
Title: ADAMTS-13 fusion constructs with dual activity against von Willebrand factor: a novel strategy for immune-mediated thrombotic thrombocytopenic purpura
Authors: Yunpeng Xue, Mark Roest, Steven J. Humphreys, Lisa N. van der Vorm, Joke Konings, Piet Meijer, Claire S. Whyte, Philip G. de Groot, Nicholas A. Arce, Renhao Li, Nicola J. Mutch, Bas de Laat, Dana Huskens
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 21, 2026, 06:38Michael Lichtenberg: Long-Term Results of Venovo Venous Stenting From the Arnsberg Venous Registry
-
Nov 21, 2026, 06:24Platelets Journal: Glycocalicin Accumulation Within Thrombi Reveals Species-Specific Mechanisms
-
Nov 21, 2026, 03:45Aref Ghanaatpisheh: The Role of Systemic Inflammation in Preoperative Deep Vein Thrombosis Risk Assessment
-
Nov 21, 2026, 03:43Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy
-
Nov 21, 2026, 03:15Amirabbas Sheykhalo: Silent Mesenteric Ischemia in Portomesenteric Thrombosis
-
Nov 21, 2026, 02:51Ivone Su: Raising Awareness of Venous Thromboembolism
-
Nov 21, 2026, 02:40Aniqa Gohar: One Heart Conclave – Advancing Integrated Thrombosis Care
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026